// App-Quantinova.ai

: - Blood plasma biomarkers improve prediction accuracy over and above genetic predictors of Alzheimer’s disease

Researchers

Presenter

  • Joshua O Stevenson-Hoare

Principal Investigators

  • Amanda Heslegrave

  • Ganna Leonenko

  • Dina Fathalla

  • Eftychia Bellou

  • Lauren Luckcuck

  • Rachel Marshall

  • Rebecca Sims

  • Paul Morgan

  • John A. Hardy

  • Bart de Strooper

  • Julie Williams

  • Henrik Zetterberg

  • Valentina Escott-Price

Medical Centers

  • VIB, KUL Center for the Biology of Disease

  • University CollegeLondon, UK

  • University of Gothenburg,

  • Cardiff University

  • UK Dementia Research Institute, University College London

  • MRC Centre for Neuropsychiatric Genetics & Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University

  • UK Dementia Research Institute at Cardiff University

  • University College London Institute of Neurology

  • UCL Institute of Neurology, London, UK

  • UK Dementia Research Institute

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Apolipoprotein E

  • Amyloid beta 40

  • Amyloid beta 42

  • Glial fibrillary acidic protein

  • Neurofilament-light chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved